The Patent Law 16(I)/1998 is the primary law governing patents in Cyprus. The law provides for the registration of patents for inventions that are new, involve an inventive step, and are capable of industrial application. The law is in line with the European Patent Convention (EPC) and the Patent Cooperation Treaty (PCT), which govern patent registration at the international level.
The Patent Law 16(I)/1998 also provides legal remedies for patent infringement. Patent holders can seek damages, injunctions, and seizure of infringing products to protect their rights and prevent others from profiting from their inventions.
Pharmaceutical, Plant Protection & Paediatric Pharmaceutical Products
Under the Patent Law 16(I)/1998, the period of protection for patents can be extended for certain types of products, including pharmaceuticals and plant protection products. In the case of these products, the period of protection can be extended to 25 years, instead of the standard 20-year period.
For pharmaceutical products, the period of protection can be extended to 25 years if the product has been authorised for sale in the European Union and meets certain conditions under the law. Specifically, the product must be a medicinal product for human use or a veterinary medicinal product, and it must have been subject to an administrative authorisation procedure in the European Union that has resulted in the issuance of a marketing authorisation. In addition, the product must not have been placed on the market in the European Union more than 5 years before the filing of the patent application.
For plant protection products, the period of protection can also be extended to 25 years if the product has been authorised for sale in the European Union and meets certain conditions under the law. Specifically, the product must be a plant protection product, and it must have been subject to an administrative authorisation procedure in the European Union that has resulted in the issuance of a marketing authorisation. In addition, the product must not have been placed on the market in the European Union more than 6 years before the filing of the patent application.
In the case of paediatric pharmaceutical products, the period of protection can be extended to 25 years and 6 months. This extension is designed to encourage the development of medicines for children, who are often underrepresented in clinical trials and may have unique medical needs. In order to be eligible for the extended period of protection, the product must be authorised for sale in the European Union and must have been studied in clinical trials in children.
Patent Infringement
Under the Patent Law 16(I)/1998, patent holders have legal remedies available to them in case of patent infringement. If someone is found to be infringing on a patent, the patent holder can seek the following legal remedies:
- Damages: The patent holder can seek damages for any financial loss suffered as a result of the infringement. This could include lost profits or other monetary damages.
- Injunctions: The patent holder can seek an injunction to prevent further infringement of the patent. This could include a court order preventing the infringing party from making, using, selling, or importing the patented invention.
- Seizure of infringing products: The patent holder can seek to have infringing products seized and destroyed. This can be an effective way to prevent further infringement and protect the intellectual property rights of the patent holder.
In order to prove infringement, the patent holder must demonstrate that the infringing party is making, using, selling, or importing the patented invention without their permission.